Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy

Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences

Volumn 369, Issue 1955, 2011, Pages 4512-4530

  Cerussi, Albert E ^a   Tanamai, Vaya W ^a   Hsiang, David ^b   Butler, John ^b   Mehta, Rita S ^b   Tromberg, Bruce J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer imaging; Multiple scattering; Near infrared; Photon migration; Therapeutic monitoring; Tissue spectroscopy

Indexed keywords

CHEMOTHERAPY; DISEASES; MONITORING; MULTIPLE SCATTERING; SURGERY; TUMORS;

CANCER IMAGING; NEAR INFRARED; PHOTON MIGRATION; THERAPEUTIC MONITORING; TISSUE SPECTROSCOPY;

MEDICAL IMAGING;

DEOXYHEMOGLOBIN; HEMOGLOBIN; LIPID; OXYHEMOGLOBIN; TUMOR MARKER; WATER;

ADJUVANT THERAPY; ARTICLE; BREAST; BREAST TUMOR; CHEMISTRY; FEMALE; HUMAN; METABOLISM; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; ONCOLOGY; OPTICS; PATHOLOGY; RADIATION SCATTERING; TIME;

BREAST; BREAST NEOPLASMS; FEMALE; HEMOGLOBINS; HUMANS; LIPIDS; MEDICAL ONCOLOGY; NEOADJUVANT THERAPY; OPTICS AND PHOTONICS; OXYHEMOGLOBINS; SCATTERING, RADIATION; SPECTROSCOPY, NEAR-INFRARED; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; WATER;

EID: 82255163801     PISSN: 1364503X     EISSN: None     Source Type: Journal    
DOI: 10.1098/rsta.2011.0279     Document Type: Article

References (54)

1. Merritt, S., Gulsen, G., Chiou, G., Chu, Y., Deng, C., Cerussi, A. E., Durkin, A. J., Tromberg, B. J. & Nalcioglu, O. 2003 Comparison of water and lipid content measurements using diffuse optical spectroscopy and MRI in emulsion phantoms. Technol. Cancer Res. Treat. 2, 563-569. (Pubitemid 38040618)
2. Cutler, M. 1929 Transillumination as an aid in the diagnosis of breast lesions. Surg. Gynecol. Obstet. 48, 721-728.
3. Boas, D. A., O'Leary, M. A., Chance, B. & Yodh, A. G. 1997 Detection and characterization of optical inhomogeneities with diffuse photon density waves: a signal-to-noise analysis. Appl. Opt. 36, 75-92. (doi:10.1364/AO.36. 000075) (Pubitemid 127615552)
4. Srinivasan, S., Pogue, B. W., Dehghani, H., Jiang, S., Song, X. & Paulsen, K. D. 2004 Improved quantification of small objects in near-infrared diffuse optical tomography. J. Biomed. Opt. 9, 1161-1171. (doi:10.1117/1. 1803545) (Pubitemid 40168130)
5. Wolff, A. C. et al. 2008 Research issues affecting preoperative systemic therapy for operable breast cancer. J. Clin. Oncol. 26, 806-813. (doi:10.1200/JCO.2007.15.2983) (Pubitemid 351264394)
6. Gralow, J. R., Zujewski, J. A. & Winer, E. 2008 Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions. J. Clin. Oncol. 26, 696-697. (doi:10.1200/JCO.2007.15.9459) (Pubitemid 351264380)
7. Jones, R. L. & Smith, I. E. 2006 Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response. Lancet Oncol. 7, 869-874. (doi:10.1016/S1470- 2045(06)70906-8) (Pubitemid 44464080)
8. Fisher, B. et al. 1997 Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J. Clin. Oncol. 15, 2483-2493. (Pubitemid 27289876)
9. Fisher, B. et al. 1998 Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J. Clin. Oncol. 16, 2672-2685. (Pubitemid 28363030)
10. Fisher, E. R.,Wang, J., Bryant, J., Fisher, B., Mamounas, E. & Wolmark, N. 2002 Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer 95, 681-695. (doi:10.1002/cncr.10741) (Pubitemid 34845919)
11. Symmans, W. F. et al. 2007 Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J. Clin. Oncol. 25, 4414-4422. (doi:10.1200/JCO.2007.10.6823) (Pubitemid 350013847)
12. Abrial, S. C. et al. 2005 High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer. Breast Cancer Res. Treat 94, 255-263. (doi:10.1007/s10549-005-9008-8) (Pubitemid 41677630)
13. Carey, L. A. et al. 2005 American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome. J. Natl. Cancer Inst. 97, 1137-1142. (doi:10.1093/jnci/dji206) (Pubitemid 41511213)
14. Mehta, R. S., Schubbert, T. & Kong, K. 2008 Trastuzumab in inflammatory breast cancer. Ann. Oncol. 19, 1815-1817. (doi:10.1093/annonc/ mdn555)
15. Yeh, E. et al. 2005 Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am. J. Roentgenol. 184, 868-877. (Pubitemid 43899515)
16. Mankoff, D. A., Dunnwald, L. K., Gralow, J. R., Ellis, G. K., Drucker, M. J. & Livingston, R. B. 1999 Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography. Cancer 85, 2410-2423. (doi:10.1002/(SICI)1097- 0142(19990601)85:11<2410::AID-CNCR16>3.0.CO;2-K) (Pubitemid 29244850)
17. Tardivon, A. A., Ollivier, L., El Khoury, C. & Thibault, F. 2006 Monitoring therapeutic efficacy in breast carcinomas. Eur. Radiol. 16, 2549-2558. (doi:10.1007/s00330-006-0317-z) (Pubitemid 44649705)
18. Chen, J. H., Feig, B. A., Hsiang, D. J., Butler, J. A., Mehta, R. S., Bahri, S., Nalcioglu, O. & Su, M. Y. 2009 Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer. Ann. Surg. 249, 448-454. (doi:10.1097/SLA.0b013e31819a6e01)
19. Warren, R. M., Bobrow, L. G., Earl, H. M., Britton, P. D., Gopalan, D., Purushotham, A. D., Wishart, G. C., Benson, J. R. & Hollingworth, W. 2004 Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br. J. Cancer 90, 1349-1360. (doi:10.1038/sj.bjc. 6601710) (Pubitemid 38586259)
20. Meisamy, S. et al. 2004 Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopy-a pilot study at 4 T. Radiology 233, 424-431. (doi:10.1148/radiol.2332031285) (Pubitemid 39423801)
21. Mankoff, D. A., Dunnwald, L. K., Gralow, J. R., Ellis, G. K., Schubert, E. K., Tseng, J., Lawton, T. J., Linden, H. M. & Livingston, R. B. 2003 Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J. Nucl. Med. 44, 1806-1814. (Pubitemid 39663314)
22. Duch, J. et al. 2009 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer. Eur. J. Nucl. Med. Mol. Imaging 36, 1551-1557. (doi:10.1007/s00259-009-1116-y)
23. Baek, H. M., Chen, J. H., Nie, K., Yu, H. J., Bahri, S., Mehta, R. S., Nalcioglu, O. & Su, M. Y. 2009 Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology 251, 653-662. (doi:10.1148/radiol.2512080553)
24. Dunnwald, L. K., Gralow, J. R., Ellis, G. K., Livingston, R. B., Linden, H. M., Lawton, T. J., Barlow, W. E., Schubert, E. K. & Mankoff, D. A. 2005 Residual tumor uptake of [99mTc]- sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival. Cancer 103, 680-688. (doi:10.1002/cncr.20831) (Pubitemid 40216394)
25. Partridge, S. C. et al. 2005 MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am. J. Roentgenol. 184, 1774-1781. (Pubitemid 40770147)
26. Padhani, A. R., Hayes, C., Assersohn, L., Powles, T., Makris, A., Suckling, J., Leach, M. O. & Husband, J. E. 2006 Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology 239, 361-374. (doi:10.1148/radiol.2392021099)
27. Linden, H. M. et al. 2006 Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J. Clin. Oncol. 24, 2793-2799. (doi:10.1200/JCO.2005.04.3810) (Pubitemid 46630578)
28. Mankoff, D. A., Dunnwald, L. K., Gralow, J. R., Ellis, G. K., Charlop, A., Lawton, T. J., Schubert, E. K., Tseng, J. & Livingston, R. B. 2002 Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J. Nucl. Med. 43, 500-509. (Pubitemid 34286345)
29. Esserman, L. et al. 2001 MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann. Surg. Oncol. 8, 549-559. (doi:10.1007/s10434-001-0549-8) (Pubitemid 32651740)
30. Johansen, R., Jensen, L. R., Rydland, J., Goa, P. E., Kvistad, K. A., Bathen, T. F., Axelson, D. E., Lundgren, S. & Gribbestad, I. S. 2009 Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI. J. Magn. Reson. Imaging 29, 1300-1307. (doi:10.1002/jmri.21778)
31. Sharma, U., Danishad, K. K., Seenu, V. & Jagannathan, N. R. 2009 Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed. 22, 104-113. (doi:10.1002/nbm.1245)
32. Emmering, J., Krak, N. C., Van der Hoeven, J. J., Spreeuwenberg, M. D., Twisk, J. W., Meijer, S., Pinedo, H. M. & Hoekstra, O. S. 2008 Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology. Ann. Oncol. 19, 1573-1577. (doi:10.1093/annonc/mdn185)
33. Jakubowski, D. B., Cerussi, A. E., Bevilacqua, F., Shah, N., Hsiang, D., Butler, J. & Tromberg, B. J. 2004 Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study. J. Biomed. Opt. 9, 230-238. (doi:10.1117/1.1629681)
34. Makris, A., Powles, T. J., Kakolyris, S., Dowsett, M., Ashley, S. E. & Harris, A. L. 1999 Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma. Cancer 85, 1996-2000. (doi:10.1002/(SICI)1097-0142(19990501)85:9 <1996::AID-CNCR17>3. 0.co;2-H) (Pubitemid 29202775)
35. Jagannathan, N. R., Singh, M., Govindaraju, V., Raghunathan, P., Coshic, O., Julka, P. K. & Rath, G. K. 1998 Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy. NMR Biomed. 11, 414-422. (doi:10.1002/(SICI)1099- 1492(199812)11:8<414::AID-NBM537>3.0.CO;2-W) (Pubitemid 29031851)
36. Shah, N., Gibbs, J., Wolverton, D., Cerussi, A., Hylton, N. & Tromberg, B. J. 2005 Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study. J. Biomed. Opt. 10, 051503. (doi:10.1117/1.2070147) (Pubitemid 44256004)
37. Choe, R. et al. 2005 Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. Med. Phys. 32, 1128-1139. (doi:10.1118/1.1869612) (Pubitemid 40586797)
38. Cerussi, A., Hsiang, D., Shah, N., Mehta, R., Durkin, A., Butler, J. & Tromberg, B. J. 2007 Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc. Natl. Acad. Sci. USA 104, 4014-4019. (doi:10.1073/pnas.0611058104) (Pubitemid 47181570)
39. Jiang, S. et al. 2009 Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes. Radiology 252, 551-560. (doi:10.1148/radiol. 2522081202)
40. Zhu, Q., Tannenbaum, S., Hegde, P., Kane, M., Xu, C. & Kurtzman, S. H. 2008 Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization. Neoplasia 10, 1028-1040.
41. Soliman, H., Gunasekara, A., Rycroft, M., Zubovits, J., Dent, R., Spayne, J., Yaffe, M. J. & Czarnota, G. J. 2010 Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer. Clin. Cancer Res. 16, 2605-2614. (doi:10.1158/1078-0432. CCR-09-1510)
42. Cerussi, A., Shah, N., Hsiang, D., Durkin, A., Butler, J. & Tromberg, B. J. 2006 In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J. Biomed. Opt. 11, 044005. (doi:10.1117/1.2337546) (Pubitemid 44803754)
43. Quaresima, V., Matcher, S. J. & Ferrari, M. 1998 Identification and quantification of intrinsic optical contrast for near-infrared mammography. Photochem. Photobiol. 67, 4-14. (doi:10.1111/j.1751-1097.1998.tb05159.x) (Pubitemid 128471955)
44. Tromberg, B. J., Shah, N., Lanning, R., Cerussi, A., Espinoza, J., Pham, T., Svaasand, L. & Butler, J. 2000 Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2, 26-40. (doi:10.1038/sj.neo.7900082) (Pubitemid 30123178)
45. Tanamai, W., Chen, C., Siavoshi, S., Cerussi, A., Hsiang, D., Butler, J. & Tromberg, B. 2009 Diffuse optical spectroscopy measurements of healing in breast tissue after core biopsy: case study. J. Biomed. Opt. 14, 014024. (doi:10.1117/1.3028012)
46. Cerussi, A., Siavoshi, S., Durkin, A., Chen, C., Tanamai, W., Hsiang, D. & Tromberg, B. J. 2009 Effect of contact force on breast tissue optical property measurements using a broadband diffuse optical spectroscopy handheld probe. Appl. Opt. 48, 4270-4277. (doi:10.1364/AO.48.004270)
47. Chen, J. H., Chang, D., Nie, K., Hsu, F. T., Shih, H. N., Hsu, C. C., Nalcioglu, O. & Su, M. Y. 2009 Comparison of breast density in the contralateral normal breast of patients with invasive and in situ breast cancer measured on MRI. Ann. Oncol. 20, 1449-1450. (doi:10.1093/annonc/mdp361)
48. Curran-Everett, D. 2000 Multiple comparisons: philosophies and illustrations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R1-R8. (Pubitemid 30625409)
49. Dunnwald, L. K. et al. 2008 Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. J. Clin. Oncol. 26, 4449-4457. (doi:10.1200/JCO.2007.15.4385)
50. Cerussi, A. E., Tanamai, V. W., Mehta, R. S., Hsiang, D., Butler, J. & Tromberg, B. J. 2010 Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient. Acad. Radiol. 17, 1031-1039. (doi:10.1016/j.acra. 2010.05.002)
51. Sorensen, A. G. 2006 Magnetic resonance as a cancer imaging biomarker. J. Clin. Oncol. 24, 3274-3281. (doi:10.1200/JCO.2006.06.6597) (Pubitemid 46622067)
52. Smith, J. J., Sorensen, A. G. & Thrall, J. H. 2003 Biomarkers in imaging: realizing radiology's future. Radiology 227, 633-638. (doi:10.1148/radiol.2273020518) (Pubitemid 36583016)
53. Tromberg, B. J., Pogue, B. W., Paulsen, K. D., Yodh, A. G., Boas, D. A. & Cerussi, A. E. 2008 Assessing the future of diffuse optical imaging technologies for breast cancer management. Med. Phys. 35, 2443-2451. (doi:10.1118/1.2919078) (Pubitemid 351748652)
54. Kukreti, S., Cerussi, A. E., Tanamai, W., Hsiang, D., Tromberg, B. J. & Gratton, E. 2010 Characterization of metabolic differences between benign and malignant tumors: high-spectralresolution diffuse optical spectroscopy. Radiology 254, 277-284. (doi:10.1148/radiol.09082134)